TriPRIL CAR T Cells in Multiple Myeloma
NCT05020444
Age 18 +
Sex Both
Phase Phase 1
Third Opinion Trial Synopsis
Scientists are doing a study to see if a new treatment called TriPRIL CAR T Cells can help people with a type of cancer called multiple myeloma that has come back or hasn't responded to other treatments. They also want to learn about any bad reactions patients might have to TriPRIL CAR T Cells. Patients who take part in the study will also receive some chemotherapy drugs that are commonly used to prepare for cancer treatment.
Scientists are doing a study to see if a new treatment called TriPRIL CAR T Cells can help people with a type of cancer called multiple myeloma that has come back or hasn't responded to other treatments. They also want to learn about any bad reactions patients might have to TriPRIL CAR T Cells. Patients who take part in the study will also receive some chemotherapy drugs that are commonly used to prepare for cancer treatment.
Third Opinion AI Generated Synopsis
Trial Summary
This research study involves the study of TriPRIL CAR T Cells for treating people with relapsed or refractory multiple myeloma and to understand the side effects when treated with TriPRIL CAR T Cells. This research study involves the study drugs:. * TriPRIL CAR T Cells * Fludarabine and Cyclophosphamide: Standardly used chemotherapy drugs as part of lymphodepleting process
This research study involves the study of TriPRIL CAR T Cells for treating people with relapsed or refractory multiple myeloma and to understand the side effects when treated with TriPRIL CAR T Cells. This research study involves the study drugs:. * TriPRIL CAR T Cells * Fludarabine and Cyclophosphamide: Standardly used chemotherapy drugs as part of lymphodepleting process
from ClinicalTrials.gov
Locations & Contact
Fill out the form and to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts:
